search URL:,https://patents.google.com/?assignee=CATALYST+PHARMACEUTICAL+PARTNERS+INC
id,title,assignee,inventor/author,priority date,filing/creation date,publication date,grant date,result link,representative figure link
US-2013041028-A1,"Methods of using (1s,3s)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid ","Northwestern University, Catalyst Pharmaceutical Partners, Inc., Brookhaven Science Associates","Richard B. Silverman, Stephen L. Dewey, Steven Miller",2010-02-25,2011-02-25,2013-02-14,,https://patents.google.com/patent/US20130041028A1/en,https://patentimages.storage.googleapis.com/c1/f7/01/827d749e3d8895/US20130041028A1-20130214-D00000.png
US-9254274-B2,Method of treating Tourette'S disorder with GABA-aminotransferase inactivators ,"Catalyst Pharmaceutical Partners, Inc., New York University, Feinstein Institute For Medical Research","Steven Miller, Jonathan D. Brodie, Stephen DEWEY",2012-01-27,2014-07-25,2016-02-09,2016-02-09,https://patents.google.com/patent/US9254274B2/en,https://patentimages.storage.googleapis.com/e6/7d/51/7de5b25ae8a673/US09254274-20160209-D00001.png
